IP Library Granted Patent US 7,544,738
Granted Patent B2
US 7,544,738 · App. 12/150,136 · Granted Jun 9, 2009

Method for the preparation of 1-benzotriazolyl carbonate esters of poly(ethylene glycol)

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,544,738
App. No.
12/150,136
Granted
Jun 9, 2009
Kind
B2
Abstract

The invention provides a method for preparing a 1-benzotriazolylcarbonate ester of a water-soluble and non-peptidic polymer by reacting a terminal hydroxyl group of a water-soluble and non-peptidic polymer with di(1-benzotriazolyl)carbonate in the presence of an amine base and an organic solvent. The polymer backbone can be poly(ethylene glycol). The 1-benzotriazolylcarbonate ester can then be reacted directly with a biologically active agent to form a biologically active polymer conjugate or reacted with an amino acid, such as lysine, to form an amino acid derivative.

Claims (3)

1. A polymer conjugate composition comprising a polymer conjugate prepared by reacting a water-soluble and non-peptidic polymer reagent composition with a biologically active agent to form the polymer conjugate composition, wherein the water-soluble and non-peptidic polymer reagent comprises a maleimide functional group and the water-soluble and non-peptidic polymer reagent is prepared by a method comprising the steps of (i) reacting a terminal hydroxyl group of a water-soluble and non-peptidic polymer bearing a terminal hydroxyl group with di(1-benzotriazolyl)carbonate to form a 1-benzotriazolylcarbonate ester of the water-soluble and non-peptidic polymer, (ii) reacting the 1-benzotriazolylcarbonate ester of the water-soluble and non-peptidic polymer with lysine to form a water-soluble and non-peptidic lysine derivative, and (iii) using the polymer lysine derivative in the formation of the water-soluble and non-peptidic reagent.

2. The polymer conjugate composition of claim 1 , wherein each water-soluble and non-peptidic polymer in the polymeric lysine derivative is a poly(ethylene glycol).

3. The polymer conjugate composition of claim 1 , wherein each poly(ethylene glycol) has an average molecule weight from about 200 Da to about 100,000.

Assignments (6)
RELEASE OF SECURITY INTEREST Recorded Apr 17, 2020
From: TC LENDING, LLC, AS COLLATERAL AGENT
To: NEKTAR THERAPEUTICS
Reel/Frame 053180/0009 →
RELEASE OF SECURITY INTEREST RECORDED AT REEL 28571, FRAME 0141 Recorded Oct 14, 2015
From: WELLS FARGO BANK, NATIONAL ASSOCIATION, AS COLLATERAL AGENT
To: NEKTAR THERAPEUTICS
Reel/Frame 036866/0700 →
GRANT OF SECURITY INTEREST IN UNITED STATES PATENTS Recorded Oct 6, 2015
From: NEKTAR THERAPEUTICS
To: TC LENDING, LLC, AS COLLATERAL AGENT
Reel/Frame 036796/0562 →
GRANT OF SECURITY INTEREST Recorded Jul 17, 2012
From: NEKTAR THERAPEUTICS
To: WELLS FARGO BANK, NATIONAL ASSOCIATION, AS COLLATERAL AGENT
Reel/Frame 028571/0141 →
MERGER Recorded Aug 31, 2009
From: NEKTAR THERAPEUTICS AL, CORPORATION
To: NEKTAR THERAPEUTICS
Reel/Frame 023196/0394 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 24, 2009
From: KOZLOWSKI, ANTONI
To: NEKTAR THERAPEUTICS AL, CORPORATION
Reel/Frame 022595/0628 →